(VIANEWS) - Texas Pacific Land (TPL), Zynex (ZYXI), CubeSmart (CUBE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Texas Pacific Land (TPL)
30.3% sales growth and 47.49% return on equity
Texas Pacific Land Trust owns tracts of Texas land.
Texas Pacific Land's sales growth this year is anticipated to be 37.1% and 1.8% for next year.
Year-on-year quarterly revenue growth grew by 97.6%, now sitting on 450.96M for the twelve trailing months.
Volume
Today's last reported volume for Texas Pacific Land is 10152 which is 63.96% below its average volume of 28172.
Texas Pacific Land's sales growth for the next quarter is 30.3%. The company's growth estimates for the present quarter and the next is 80.4% and 26.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 47.49%.
Volatility
Texas Pacific Land's last day, last week, and last month's current intraday variation average was 0.18%, 0.73%, and 1.98%, respectively.
Texas Pacific Land's highest amplitude of average volatility was 3.14% (day), 3.42% (last week), and 3.75% (last month), respectively.
Texas Pacific Land's Stock Yearly Top and Bottom Value
Texas Pacific Land's stock is valued at $1,813.00 at 11:22 EST, higher than its 52-week high of $1,756.00.
Texas Pacific Land's Moving Average
Texas Pacific Land's worth is way above its 50-day moving average of $1,473.79 and way above its 200-day moving average of $1,295.95.2. Zynex (ZYXI)
20.7% sales growth and 29.08% return on equity
Zynex, Inc., via its subsidiaries, designs, produces, and markets medical products to treat acute and chronic pain. It also activates and exercises muscles for rehabilitation purposes using electrical stimulation.
Zynex's sales growth this year is anticipated to be 22.1% and 24.5% for next year.
Year-on-year quarterly revenue growth grew by 28.8%, now sitting on 137.26M for the twelve trailing months.
Volume
Today's last reported volume for Zynex is 242439 which is 45.13% below its average volume of 441919.
Zynex's sales growth for the next quarter is 20.7%. The company's growth estimates for the current quarter and the next is a negative 0% and negative -20%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.08%.
Volatility
Zynex's last day, last week, and last month's current intraday variation average was 0.13%, 1.07%, and 3.90%, respectively.
Zynex's highest amplitude of average volatility was 7.44% (day), 5.52% (last week), and 7.58% (last month), respectively.
Zynex's Stock Yearly Top and Bottom Value
Zynex's stock is valued at $7.62 at 11:22 EST, way under its 52-week high of $16.26 and way above its 52-week low of $4.97.
Zynex's Moving Average
Zynex's worth is above its 50-day moving average of $7.50 and below its 200-day moving average of $8.37.3. CubeSmart (CUBE)
20% sales growth and 8.85% return on equity
CubeSmart, a trust that invests in real estate and is self-managed and managed by CubeSmart, can be found here.
CubeSmart's sales growth this year is anticipated to be 20.2% and 6.7% for next year.
Year-on-year quarterly revenue growth grew by 26.2%, now sitting on 874.51M for the twelve trailing months.
Volume
Today's last reported volume for CubeSmart is 557646 which is 67.04% below its average volume of 1692380.
CubeSmart's sales growth for the next quarter is 20%. The company's growth estimates for the ongoing quarter and the next is 12.5% and negative -34.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.85%.
Volatility
CubeSmart's last day, last week, and last month's current intraday variation average was 0.79%, 1.07%, and 1.19%, respectively.
CubeSmart's highest amplitude of average volatility was 1.71% (day), 2.01% (last week), and 2.30% (last month), respectively.
CubeSmart's Stock Yearly Top and Bottom Value
CubeSmart's stock is valued at $43.62 at 11:22 EST, way below its 52-week high of $57.34 and way above its 52-week low of $38.67.
CubeSmart's Moving Average
CubeSmart's worth is higher than its 50-day moving average of $42.41 and way below its 200-day moving average of $49.62.4. Pinnacle Financial Partners (PNFP)
13.8% sales growth and 10.37% return on equity
Pinnacle Financial Partners, Inc., along with its affiliates, is the bank holding company of Pinnacle Bank, which provides many banking products and services throughout the United States.
Pinnacle Financial Partners's sales growth this year is expected to be 24.9% and 13.5% for next year.
Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 1.34B for the twelve trailing months.
Volume
Today's last reported volume for Pinnacle Financial Partners is 663787 which is 42.47% above its average volume of 465885.
Pinnacle Financial Partners's sales growth for the next quarter is 13.8%. The company's growth estimates for the present quarter and the next is a negative 1.2% and 4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.37%.
Volatility
Pinnacle Financial Partners's last day, last week, and last month's current intraday variation average was 0.65%, 0.83%, and 1.70%, respectively.
Pinnacle Financial Partners's highest amplitude of average volatility was 1.58% (day), 1.88% (last week), and 2.78% (last month), respectively.
Pinnacle Financial Partners's Stock Yearly Top and Bottom Value
Pinnacle Financial Partners's stock is valued at $79.10 at 11:22 EST, way under its 52-week high of $111.31 and way above its 52-week low of $67.86.
Pinnacle Financial Partners's Moving Average
Pinnacle Financial Partners's value is higher than its 50-day moving average of $75.30 and way under its 200-day moving average of $90.02.5. Tower Semiconductor Ltd. (TSEM)
12.9% sales growth and 11.44% return on equity
Tower Semiconductor Ltd. is an independent semiconductor findry that manufactures and sells analog intensive mixed signal semiconductor devices throughout the United States, Japan and Asia.
Tower Semiconductor Ltd.'s sales growth this year is expected to be 14.4% and 5.8% for next year.
Year-on-year quarterly revenue growth grew by 21.3%, now sitting on 1.58B for the twelve trailing months.
Volume
Today's last reported volume for Tower Semiconductor Ltd. is 1001670 which is 48.99% above its average volume of 672277.
Tower Semiconductor Ltd.'s sales growth for the next quarter is 12.9%. The company's growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.44%.
Volatility
Tower Semiconductor Ltd.'s last day, last week, and last month's current intraday variation average was 1.18%, 1.00%, and 0.62%, respectively.
Tower Semiconductor Ltd.'s highest amplitude of average volatility was 2.17% (day), 1.14% (last week), and 1.08% (last month), respectively.
Tower Semiconductor Ltd.'s Stock Yearly Top and Bottom Value
Tower Semiconductor Ltd.'s stock is valued at $47.86 at 11:22 EST, under its 52-week high of $49.13 and way higher than its 52-week low of $26.59.
Tower Semiconductor Ltd.'s Moving Average
Tower Semiconductor Ltd.'s value is above its 50-day moving average of $46.71 and way above its 200-day moving average of $42.41.6. Edwards Lifesciences (EW)
10.6% sales growth and 29.3% return on equity
Edwards Lifesciences Corporation offers products and technology for critical care, surgical monitoring and structural heart disease in the United States as well as internationally.
Edwards Lifesciences's sales growth this year is expected to be 9.5% and 12% for next year.
Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 5.36B for the twelve trailing months.
Volume
Today's last reported volume for Edwards Lifesciences is 770089 which is 72.07% below its average volume of 2757810.
Edwards Lifesciences's sales growth for the next quarter is 10.6%. The company's growth estimates for the current quarter and the next is a negative 0% and 18.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.3%.
Volatility
Edwards Lifesciences's last day, last week, and last month's current intraday variation average was 6.71%, 2.45%, and 1.56%, respectively.
Edwards Lifesciences's highest amplitude of average volatility was 3.35% (day), 2.60% (last week), and 2.62% (last month), respectively.
Edwards Lifesciences's Stock Yearly Top and Bottom Value
Edwards Lifesciences's stock is valued at $100.53 at 11:22 EST, way below its 52-week high of $131.73 and way higher than its 52-week low of $85.58.
Edwards Lifesciences's Moving Average
Edwards Lifesciences's value is higher than its 50-day moving average of $96.69 and below its 200-day moving average of $109.83.7. Option Care Health (OPCH)
9.6% sales growth and 15.45% return on equity
Option Care Health, Inc. provides infusion services at home or on an alternate location in the United States.
Option Care Health's sales growth this year is anticipated to be 11.9% and 8.1% for next year.
Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 3.6B for the twelve trailing months.
Volume
Today's last reported volume for Option Care Health is 573885 which is 45.31% below its average volume of 1049450.
Option Care Health's sales growth is a negative 0% for the current quarter and 9.6% for the next. The company's growth estimates for the current quarter and the next is 22.2% and 20%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.45%.
Volatility
Option Care Health's last day, last week, and last month's current intraday variation average was 2.18%, 2.54%, and 2.15%, respectively.
Option Care Health's highest amplitude of average volatility was 3.11% (day), 4.19% (last week), and 3.91% (last month), respectively.
Option Care Health's Stock Yearly Top and Bottom Value
Option Care Health's stock is valued at $31.44 at 11:22 EST, under its 52-week high of $32.21 and way higher than its 52-week low of $20.06.
Option Care Health's Moving Average
Option Care Health's value is above its 50-day moving average of $28.60 and way higher than its 200-day moving average of $26.78.8. NiSource (NI)
7.7% sales growth and 10.68% return on equity
NiSource Inc. is an energy holding company that operates in the United States as a regulated electric utility and natural gas company.
NiSource's sales growth this year is expected to be 8.6% and 3.9% for next year.
Year-on-year quarterly revenue growth grew by 21.2%, now sitting on 5.23B for the twelve trailing months.
Volume
Today's last reported volume for NiSource is 3959360 which is 12.88% below its average volume of 4544950.
NiSource's sales growth for the next quarter is 7.7%. The company's growth estimates for the current quarter and the next is a negative 0% and 9.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.68%.
Volatility
NiSource's last day, last week, and last month's current intraday variation average was 1.25%, 0.89%, and 1.21%, respectively.
NiSource's highest amplitude of average volatility was 1.28% (day), 1.54% (last week), and 2.19% (last month), respectively.
NiSource's Stock Yearly Top and Bottom Value
NiSource's stock is valued at $28.44 at 11:22 EST, way below its 52-week high of $32.59 and way higher than its 52-week low of $23.65.